The store will not work correctly when cookies are disabled.
Ethyl 4-(2,4-diiodophenylamino)-2-oxo-6-phenylcyclohex-3-en-1-oate
ID: ALA3125609
PubChem CID: 76321818
Max Phase: Preclinical
Molecular Formula: C21H19I2NO3
Molecular Weight: 587.19
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)C1C(=O)C=C(Nc2ccc(I)cc2I)CC1c1ccccc1
Standard InChI: InChI=1S/C21H19I2NO3/c1-2-27-21(26)20-16(13-6-4-3-5-7-13)11-15(12-19(20)25)24-18-9-8-14(22)10-17(18)23/h3-10,12,16,20,24H,2,11H2,1H3
Standard InChI Key: LVHHYACWXXQNSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
5.4668 -8.6460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4668 -9.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1788 -9.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8909 -9.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8909 -8.6460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1788 -8.2294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6048 -9.8846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7529 -9.8846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1788 -10.7045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4644 -11.1169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8933 -11.1169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4644 -11.9419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1788 -7.4044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8933 -6.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6066 -7.4086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3207 -6.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3211 -6.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6015 -5.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8905 -6.1727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0364 -5.7605 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
6.1729 -5.7597 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
4.0385 -9.4719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3251 -9.8848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3259 -10.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0460 -11.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7564 -10.7067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7499 -12.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
2 8 1 0
3 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
6 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
19 21 1 0
8 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 8 1 0
12 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 587.19 | Molecular Weight (Monoisotopic): 586.9454 | AlogP: 5.13 | #Rotatable Bonds: 5 |
Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.59 | CX Basic pKa: ┄ | CX LogP: 5.61 | CX LogD: 5.61 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.30 | Np Likeness Score: -0.56 |
References
1. Edafiogho IO, Qaddoumi MG, Ananthalakshmi KV, Phillips OA, Kombian SB.. (2014) Synthesis, neuronal activity and mechanisms of action of halogenated enaminones., 76 [PMID:24565570] [10.1016/j.ejmech.2014.02.002] |